Cohen Klingenstein’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Hold |
6,000
| – | – | 0.09% | 97 |
|
|
2025
Q1 | $2.91M | Hold |
6,000
| – | – | 0.11% | 90 |
|
|
2024
Q4 | $2.42M | Hold |
6,000
| – | – | 0.08% | 104 |
|
|
2024
Q3 | $2.79M | Hold |
6,000
| – | – | 0.1% | 108 |
|
|
2024
Q2 | $2.81M | Hold |
6,000
| – | – | 0.1% | 103 |
|
|
2024
Q1 | $2.51M | Hold |
6,000
| – | – | 0.09% | 110 |
|
|
2023
Q4 | $2.44M | Hold |
6,000
| – | – | 0.1% | 111 |
|
|
2023
Q3 | $2.09M | Hold |
6,000
| – | – | 0.09% | 114 |
|
|
2023
Q2 | $2.11M | Hold |
6,000
| – | – | 0.09% | 117 |
|
|
2023
Q1 | $1.89M | Hold |
6,000
| – | – | 0.09% | 119 |
|
|
2022
Q4 | $1.73M | Hold |
6,000
| – | – | 0.09% | 130 |
|
|
2022
Q3 | $1.74M | Hold |
6,000
| – | – | 0.09% | 119 |
|
|
2022
Q2 | $1.69M | Hold |
6,000
| – | – | 0.08% | 127 |
|
|
2022
Q1 | $1.57M | Hold |
6,000
| – | – | 0.07% | 136 |
|
|
2021
Q4 | $1.32M | Hold |
6,000
| – | – | 0.05% | 152 |
|
|
2021
Q3 | $1.09M | Hold |
6,000
| – | – | 0.05% | 170 |
|
|
2021
Q2 | $1.21M | Hold |
6,000
| – | – | 0.05% | 170 |
|
|
2021
Q1 | $1.29M | Hold |
6,000
| – | – | 0.06% | 157 |
|
|
2020
Q4 | $1.42M | Hold |
6,000
| – | – | 0.07% | 146 |
|
|
2020
Q3 | $1.63M | Hold |
6,000
| – | – | 0.09% | 127 |
|
|
2020
Q2 | $1.74M | Hold |
6,000
| – | – | 0.11% | 124 |
|
|
2020
Q1 | $1.43M | Hold |
6,000
| – | – | 0.11% | 122 |
|
|
2019
Q4 | $1.31M | Hold |
6,000
| – | – | 0.08% | 142 |
|
|
2019
Q3 | $1.02M | Buy |
+6,000
| New | +$1.02M | 0.06% | 155 |
|